Company Profile

AtlasXomics Inc
Profile last edited on: 10/30/23      CAGE: 8MSC0      UEI: LVJJTHPGMQJ9

Business Identifier: Comprehensive spatial epigenome solution at cellular resolution
Year Founded
2020
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5 Science Park
New Haven, CT 06511
   (978) 495-1162
   info@atlasxomics.com
   www.atlasxomics.com
Location: Single
Congr. District: 03
County: New Haven

Public Profile

Spun out of Yale, AtlasXomics structured around commercializing a novel discovery platformproviding clinicians and researchers with unprecedented multi-omics tissue atlases. Called “Deterministic Barcoding in Tissue for spatial-omics sequencing” (DBiT-seq), the platform was developed by Dr. Rong Fan, Professor of Biomedical Engineering at Yale University. Leveraging microfluidics and next generation sequencing (NGS) to create transformative multi-omic maps (proteomics, transcriptomics, and epigenomics) in tissue at cellular resolution, unlocking information about interactions between cells in localized neighborhoods. Published in Cell in 2020. DBiT-seq is usefully understiid as the first platform to offer spatial ATAC-seq and spatial CUT & Tag for mapping chromatin accessibility and histone modifications across the entire genome in tiss

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
20-24
Revenue Range
2M-2.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Jennifer Garbarino -- Principal Scientist

  Joseph Gennaro

  Zev Kartiganer -- Principal Engineer

  Daniel Massucci -- Operations Manager

  Colin Ng -- Vice President Vusiness Development

  Jeffrey Sabina -- Director of R&D

  Kenneth Wang -- CEO

Company News

There are no news available.